Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment
Imaging services provider Medcrossis joining forces with Magnecel Services (MSI) to access the potentiallylucrative Asia-Pacific market. The two companies have formed ajoint venture firm, Medpacific, to sell and service Elscint medicalimaging equipment and linear accelerators.
The move is a logical step for the companies, both of whichare based in Florida. Medcross recently signed a joint ventureagreement with the Chinese Health Ministry to import CT scannersinto China, while third-party service provider Magnecel is theexclusive Florida sales and service organization for Elscint medicalimaging products.
Medcross is the majority shareholder in the venture.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
July 29th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.